CD19 Expressing Cell Count

Known as: CD19 
The determination of the amount of the CD19 expressing cells in a sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Epratuzumab, a humanized anti-CD22 antibody, is currently in clinical trials of B-cell lymphomas and autoimmune diseases… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Rituximab (RTX) is a new treatment strategy in high-degree steroid-dependent idiopathic nephrotic syndrome (SDNS) in childhood… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The CD19 protein forms a complex with CD21, CD81, and CD225 in the membrane of mature B cells. Together with the B… (More)
Is this relevant?
2006
2006
BACKGROUND Contemporary risk adapted treatment protocols for childhood acute lymphoblastic leukemia (ALL) rely on accurate risk… (More)
Is this relevant?
2000
2000
Over a period of 14 years, 50 patients (12 children and 38 adults) of whom 46 had acute myeloid leukemia (AML) and 4 had… (More)
Is this relevant?
1999
1999
The TEL:AML1 fusion gene product which results from the chromosomal translocation t(12;21) is the most common genetic lesion in… (More)
Is this relevant?
1993
1993
Acute leukemias (ALs) with phenotypic and genotypic features of several hematopoietic lineages are difficult to classify and may… (More)
Is this relevant?
1993
1993
Results of immunophenotypic examinations of peripheral blood and/or bone marrow (BM), involved in low-grade B-cell non-Hodgkin's… (More)
Is this relevant?